WANG Lei,GAO Guo-yi,JIANG JI yao. Research advances in gene polymorphism affecting prognosis of traumatic brain injury[J]. CHINESE JOURNAL OF TRAUMA, 2013, 29(9): 896-899.
［1］Weaver SM, Chau A, Portelli JN, et al. Genetic polymorphisms influence recovery from traumatic brain injury. Neuroscientist, 2012, 18(6):631-644.
［2］Myburgh JA, Cooper DJ, Finfer SR, et al. Epidemiology and 12-month outcomes from traumatic brain injury in australia and new zealand. J Trauma, 2008, 64(4):854-862.
［3］McAllister TW, Tyler AL, Flashman LA, et al. Polymorphisms in the brain-derived neurotrophic factor gene influence memory andprocessing speed one month after brain injury. J Neurotrauma, 2012,29(6):1111-1118.
［4］Hoh NZ, Wagner AK, Alexander SA, et al. BCL2 genotypes: functional and neurobehavioral outcomes after severe traumatic brain injury. J Neurotrauma, 2010,27(8):1413-1427.
［5］McAllister TW, Flashman LA, Harker RC, et al. Single nucleotide polymorphisms in ANKK1 and the dopamine D2 receptor gene affect cognitive outcome shortly after traumatic brain injury: a replication and extension study. Brain Inj, 2008, 22(9):705-714.
［6］Dardiotis E, Fountas KN, Dardioti M, et al. Genetic association studies in patients with traumatic brain injury. Neurosurg Focus, 2010, 28(1):E9.
［7］Jiang Y, Sun X, Xia Y, et al. Effect of APOE polymorphisms on early responses to traumatic brain injury. Neurosci Lett, 2006, 408(2):155-158.
［8］Krueger F, Pardini M, Huey ED, et al. The role of the Met66 brain-derived neurotrophic factor allele in the recovery of executive functioning after combat-related traumatic brain injury. J Neurosci, 2011, 31(2):598-606.
［9］Teasdale GM, Murray GD, Nicoll JA. The association between APOE epsilon4, age and outcome after head injury: a prospective cohort study. Brain, 2005,128(Pt 11):2556-2561.
［10］Wilson M, Montgomery H. Impact of genetic factors on outcome from brain injury. Br J Anaesth, 2007, 99(1):43-48.
［14］Ariza M, Pueyo R, Matain Mdel M, et al. Influence of APOE polymorphism on cognitive and behavioural outcome in moderate and severe traumatic brain injury. J Neurol Neurosurg Psychiatry, 2006, 77(10):1191-1193.
［15］Willemse-van Son AH, Ribbers GM, Hop WC, et al. Association between apolipoprotein-epsilon4 and long-term outcome after traumatic brain injury. J Neurol Neurosurg Psychiatry, 2008, 79(4):426-430.
［16］Rostami E, Krueger F, Zoubak S, et al. BDNF polymorphism predicts general intelligence after penetrating traumatic brain injury. PLoS One, 2011, 6(11):e27389.
［17］Shang A, Liu K, Wang H, et al. Neuroprotective effects of neuroglobin after mechanical injury. Neurol Sci, 2012, 33(3):551-558.
［18］Chuang PY, Conley YP, Poloyac SM, et al. Neuroglobin genetic polymorphisms and their relationship to functional outcomes after traumatic brain injury. J Neurotrauma, 2010, 27(6):999-1006.
［19］Minambres E, Ballesteros MA, Mayorga M, et al. Cerebral apoptosis in severe traumatic brain injury patients: an in vitro, in vivo, and postmortem study. J Neurotrauma, 2008, 25(6):581-591.
［20］Pacher P, Szabot C. Role of the peroxynitrite-poly (ADP-ribose) polymerase pathway in human disease. Am J Pathol, 2008, 173(1):2-13.
［21］Sarnaik AA, Conley YP, Okonkwo DO, et al. Influence of PARP-1 polymorphisms in patients after traumatic brain injury. J Neurotrauma, 2010, 27(3):465-471.
［22］Thomas M, Kalita A, Labrecque S, et al. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol, 1999, 19(2):1092-1100.
［23］Dumont P, Leu JI, Della Pietra AC 3rd, et al. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet, 2003, 33(3):357-365.
［24］Martinez-Lucas P, Moreno-Cuesta J, Garcia-Olmo DC, et al. Relationship between the Arg72Pro polymorphism of p53 and outcome for patients with traumatic brain injury. Intensive Care Med, 2005, 31(9):1168-1173.
［25］Ariza M, Del Matarin M, Junque C, et al. Influence of angiotensin-converting enzyme polymorphism on neuropsychological subacute performance in moderate and severe traumatic brain injury. J Neuropsychiatry Clin Neurosci, 2006, 18(1):39-44.
［26］Kehoe AD, Eleftheriou KI, Heron M, et al. Angiotensin-converting enzyme genotype may predict survival following major trauma. Emerg Med J, 2008, 25(11):759-761.
［27］Spooren A, Kolmus K, Laureys G, et al. Interleukin-6, a mental cytokine. Brain Res Rev, 2011, 67(1-2):157-183.〖JP〗
［28］Erta M, Quintana A, Hidalgo J. Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci, 2012, 8(9):1254-1266.
［29］Dalla Libera A, Regner A, de Paoli J, et al. IL-6 polymorphism associated with fatal outcome in patients with severe traumatic brain injury. Brain Inj, 2011, 25(4):365-369.
［30］McAllister TW. Polymorphisms in genes modulating the dopamine system: do they influence outcome and response to medication after traumatic brain injury? J Head Trauma Rehabil, 2009, 24(1):65-68.
